These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38375956)

  • 61. Small for gestational age birth may increase airflow limitation in bronchopulmonary dysplasia.
    Kim YH; Kim KW; Eun HS; Shin JE; Sol IS; Kim SY; Kim YS; Sohn MH; Namgung R
    Pediatr Pulmonol; 2020 Feb; 55(2):346-353. PubMed ID: 31794162
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Measurement of lung oxygenation by near-infrared spectroscopy in preterm infants with bronchopulmonary dysplasia.
    Dani C; Miselli F; Zini T; Scarponi D; Luzzati M; Sarcina D; Fusco M; Dianori F; Berardi A
    Pediatr Pulmonol; 2024 Jun; 59(6):1631-1637. PubMed ID: 38441387
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Late (≥ 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
    Onland W; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2022 Dec; 12(12):CD002311. PubMed ID: 36521169
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [A clinical analysis of neurobehavioral development within one year after birth in preterm infants with bronchopulmonary dysplasia].
    Gu J; Liang SZ; Shi BJ; Lian CY; Zhong XQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Jun; 22(6):583-588. PubMed ID: 32571456
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Association between serum 25(OH)D levels at birth and bronchopulmonary dysplasia in preterm infants].
    Yu RQ; Chen DZ; Zhou Q; Wang M; Mei YZ; Jiang SY
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Oct; 19(10):1051-1055. PubMed ID: 29046199
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial.
    Onland W; Cools F; Kroon A; Rademaker K; Merkus MP; Dijk PH; van Straaten HL; Te Pas AB; Mohns T; Bruneel E; van Heijst AF; Kramer BW; Debeer A; Zonnenberg I; Marechal Y; Blom H; Plaskie K; Offringa M; van Kaam AH;
    JAMA; 2019 Jan; 321(4):354-363. PubMed ID: 30694322
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Severity of bronchopulmonary dysplasia and increased risk of feeding desaturation and growth delay in very low birth weight preterm infants.
    Wang LY; Luo HJ; Hsieh WS; Hsu CH; Hsu HC; Chen PS; Chiu NC; Lee WT; Jeng SF
    Pediatr Pulmonol; 2010 Feb; 45(2):165-73. PubMed ID: 20054861
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reduced pulmonary oxygen diffusion at 36 weeks of postmenstrual age in small-for-gestational-age preterm infants of less than 32 weeks without bronchopulmonary dysplasia.
    Correani A; Lanciotti L; Giorgetti C; Palazzi ML; Monachesi C; Antognoli L; Burattini I; Cogo P; Carnielli V
    Pediatr Pulmonol; 2023 Nov; 58(11):3054-3062. PubMed ID: 37594147
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neurodevelopmental outcomes in very preterm infants: The role of severity of Bronchopulmonary Dysplasia.
    Gallini F; Coppola M; De Rose DU; Maggio L; Arena R; Romano V; Cota F; Ricci D; Romeo DM; Mercuri EM; Vento G
    Early Hum Dev; 2021 Jan; 152():105275. PubMed ID: 33227635
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [A comparison of the clinical diagnosis and outcome in preterm infants with bronchopulmonary dysplasia under two different diagnostic criteria].
    Wang CH; Shen XX; Chen MY; Ma XL; Shi LP; Du LZ
    Zhonghua Er Ke Za Zhi; 2020 May; 58(5):381-386. PubMed ID: 32392953
    [No Abstract]   [Full Text] [Related]  

  • 71. Home Oxygen Use and 1-Year Readmission among Infants Born Preterm with Bronchopulmonary Dysplasia Discharged from Children's Hospital Neonatal Intensive Care Units.
    Lagatta J; Murthy K; Zaniletti I; Bourque S; Engle W; Rose R; Ambalavanan N; Brousseau D
    J Pediatr; 2020 May; 220():40-48.e5. PubMed ID: 32093927
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Predictive Ability of the New Bronchopulmonary Dysplasia Definition on Pulmonary Outcomes at 20 to 24 Months' Corrected Age of Preterm Infants.
    Saengrat P; Limrungsikul A
    Am J Perinatol; 2023 Aug; 40(11):1232-1239. PubMed ID: 34492722
    [TBL] [Abstract][Full Text] [Related]  

  • 73. N-terminal-probrain natriuretic peptide as a biomarker of moderate to severe bronchopulmonary dysplasia in preterm infants: A prospective observational study.
    Rodríguez-Blanco S; Oulego-Erroz I; Alonso-Quintela P; Terroba-Seara S; Jiménez-González A; Palau-Benavides M
    Pediatr Pulmonol; 2018 Aug; 53(8):1073-1081. PubMed ID: 29790673
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Volumetric Capnography at 36 Weeks Postmenstrual Age and Bronchopulmonary Dysplasia in Very Preterm Infants.
    Neumann RP; Gerull R; Zannin E; Fouzas S; Schulzke SM
    J Pediatr; 2022 Feb; 241():97-102.e2. PubMed ID: 34687691
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A modified lung ultrasound score to evaluate short-term clinical outcomes of bronchopulmonary dysplasia.
    Sun YH; Du Y; Shen JR; Ai DY; Huang XY; Diao SH; Lin SB; Zhang R; Yuan L; Yang YP; He LL; Qin XJ; Zhou JG; Chen C
    BMC Pulm Med; 2022 Mar; 22(1):95. PubMed ID: 35305612
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Clinical significance of amplitude-integrated electroencephalography in preterm infants with bronchopulmonary dysplasia].
    Zhang Y; Fu JM; Xia SW
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Feb; 23(2):127-132. PubMed ID: 33627205
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Platelet is the early predictor of bronchopulmonary dysplasia in very premature infants: an observational cohort study.
    Wang X; Ma Y; Wang S; Dong W; Lei X
    BMC Pulm Med; 2022 Mar; 22(1):109. PubMed ID: 35346143
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Structural and Functional Lung Impairment in Adult Survivors of Bronchopulmonary Dysplasia.
    Caskey S; Gough A; Rowan S; Gillespie S; Clarke J; Riley M; Megarry J; Nicholls P; Patterson C; Halliday HL; Shields MD; McGarvey L
    Ann Am Thorac Soc; 2016 Aug; 13(8):1262-70. PubMed ID: 27222921
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.
    Dargaville PA; Kamlin COF; Orsini F; Wang X; De Paoli AG; Kanmaz Kutman HG; Cetinkaya M; Kornhauser-Cerar L; Derrick M; Özkan H; Hulzebos CV; Schmölzer GM; Aiyappan A; Lemyre B; Kuo S; Rajadurai VS; O'Shea J; Biniwale M; Ramanathan R; Kushnir A; Bader D; Thomas MR; Chakraborty M; Buksh MJ; Bhatia R; Sullivan CL; Shinwell ES; Dyson A; Barker DP; Kugelman A; Donovan TJ; Tauscher MK; Murthy V; Ali SKM; Yossuck P; Clark HW; Soll RF; Carlin JB; Davis PG;
    JAMA; 2021 Dec; 326(24):2478-2487. PubMed ID: 34902013
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD001145. PubMed ID: 34758507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.